Related Experiment Video
Updated: Aug 17, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Regulation of mTOR and cell growth in response to energy stress by REDD1
Avi Sofer1, Kui Lei, Cory M Johannessen
1Massachusetts General Hospital Cancer Center and Harvard Medical School, GRJ-904, 55 Fruit Street, Boston, Massachusetts 02114, USA.
Abstract:
The tuberous sclerosis tumor suppressors TSC1 and TSC2 regulate the mTOR pathway to control translation and cell growth in response to nutrient and growth factor stimuli. We have recently identified the stress response REDD1 gene as a mediator of tuberous sclerosis complex (TSC)-dependent mTOR regulation by hypoxia. Here, we demonstrate that REDD1 inhibits mTOR function to control cell growth in response to energy stress. Endogenous REDD1 is induced following energy stress, and REDD1-/- cells are highly defective in dephosphorylation of the key mTOR substrates S6K and 4E-BP1 following either ATP depletion or direct activation of the AMP-activated protein kinase (AMPK). REDD1 likely acts on the TSC1/2 complex, as regulation of mTOR substrate phosphorylation by REDD1 requires TSC2 and is blocked by overexpression of the TSC1/2 downstream target Rheb but is not blocked by inhibition of AMPK. Tetracycline-inducible expression of REDD1 triggers rapid dephosphorylation of S6K and 4E-BP1 and significantly decreases cellular size. Conversely, inhibition of endogenous REDD1 by short interfering RNA increases cell size in a rapamycin-sensitive manner, and REDD1-/- cells are defective in cell growth regulation following ATP depletion. These results define REDD1 as a critical transducer of the cellular response to energy depletion through the TSC-mTOR pathway.
Insights
The stress response gene REDD1 controls cell growth by inhibiting the mTOR pathway during energy depletion. This finding reveals REDD1 as a key regulator in the tuberous sclerosis complex-mTOR signaling pathway.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- The tuberous sclerosis tumor suppressors TSC1 and TSC2 are critical regulators of the mechanistic target of rapamycin (mTOR) pathway, controlling cell growth and translation.
- The REDD1 gene was previously identified as a mediator of TSC-dependent mTOR regulation by hypoxia.
Purpose of the Study:
- To investigate the role of REDD1 in mediating the cellular response to energy stress through the TSC-mTOR pathway.
- To elucidate the mechanism by which REDD1 regulates mTOR function during energy depletion.
Main Methods:
- Utilized REDD1 knockout (REDD1-/-) cells and cells with tetracycline-inducible REDD1 expression.
- Assessed mTOR substrate phosphorylation (S6K, 4E-BP1) following ATP depletion or AMP-activated protein kinase (AMPK) activation.
- Investigated the interaction with the TSC1/2 complex and Rheb.
- Measured cellular size changes in response to REDD1 modulation and rapamycin treatment.
Main Results:
- Endogenous REDD1 is induced by energy stress, and its absence impairs mTOR substrate dephosphorylation.
- REDD1 inhibition of mTOR requires TSC2 and is independent of AMPK, but dependent on Rheb.
- Inducible REDD1 expression decreases cell size, while REDD1 deficiency leads to defective growth regulation under energy stress.
- Knockdown of REDD1 increases cell size in a rapamycin-sensitive manner.
Conclusions:
- REDD1 acts as a crucial transducer of the cellular response to energy depletion via the TSC-mTOR pathway.
- REDD1 directly inhibits mTOR signaling to control cell growth during periods of low energy availability.
- These findings highlight REDD1 as a key player in cellular energy homeostasis and growth control.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response
Negative Regulator Molecules
Mitogens and the Cell Cycle

